Letter to the Editor | Published:

Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q

Leukemia volume 29, pages 19421945 (2015) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , , , , et al. Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS. Cancer Cell 2014; 26: 509–520.

  2. 2.

    , , , , , et al. Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo. Cancer Cell 2014; 25: 794–808.

  3. 3.

    , , , , , et al. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat Genet 2011; 44: 53–57.

  4. 4.

    , , , , , et al. CKIalpha ablation highlights a critical role for p53 in invasiveness control. Nature 2011; 470: 409–413.

  5. 5.

    , , , , , et al. Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia. J Exp Med 2014; 211: 605–612.

  6. 6.

    , , , , , et al. Suppression of casein kinase 1alpha in melanoma cells induces a switch in beta-catenin signaling to promote metastasis. Cancer Res 2010; 70: 6999–7009.

  7. 7.

    , , , , , et al. Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays. Haematologica 2008; 93: 994–1000.

  8. 8.

    , , , , , et al. Identification of RPS14 as a 5q− syndrome gene by RNA interference screen. Nature 2008; 451: 335–339.

  9. 9.

    , , , , , et al. Identification of miR-145 and miR-146a as mediators of the 5q− syndrome phenotype. Nat Med 2010; 16: 49–58.

  10. 10.

    , , , , , et al. TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression. J Clin Oncol 2011; 29: 1971–1979.

  11. 11.

    , , , , , et al. Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS. Leukemia 2014; 28: 1033–1040.

  12. 12.

    , , , , , et al. Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes. J Clin Oncol 2011; 29: 2499–2506.

  13. 13.

    , , , , , et al. SETBP1 mutation analysis in 944 patients with MDS and AML. Leukemia 2013; 27: 2072–2075.

Download references

Acknowledgements

We are indebted to all patients and contributing doctors. This study was supported by grants 110284, 110287, 110292 and 111267 from Deutsche Krebshilfe; grant DJCLS R13/14 from the Deutsche José Carreras Leukämie-Stiftung eV; the German Federal Ministry of Education and Research grant 01EO0802 (IFB-Tx); DFG grant HE 5240/5-1 and HE 5240/6-1; and grants from Dieter-Schlag Stiftung.

Author information

Affiliations

  1. Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

    • M Heuser
    • , M M A Cruz
    • , J Fabisch
    • , S Klesse
    • , L Köhler
    • , V Panagiota
    • , C Koenecke
    • , S Ehrlich
    • , K Stamer
    •  & A Ganser
  2. MLL Munich Leukemia Laboratory, Munich, Germany

    • M Meggendorfer
    • , C Haferlach
    • , T Haferlach
    •  & F Thol
  3. Institute of Human Genetics, Hannover Medical School, Hannover, Germany

    • G Göhring
    •  & B Schlegelberger
  4. Department of Hematology and Oncology, Georg-August-Universität Göttingen, Göttingen, Germany

    • C Ganster
    • , K Shirneshan
    • , A Gutermuth
    •  & D Haase
  5. Department of Hematology and Hemostasis, Medical University Vienna, Vienna, Austria

    • S Cerny-Reiterer
    •  & P Valent
  6. Department of Internal Medicine III, University of Ulm, Ulm, Germany

    • J Krönke
    •  & K Döhner
  7. Medical Department I, University Hospital Carl Gustav Carus, Dresden, Germany

    • U Platzbecker
    •  & C Thiede
  8. Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Duesseldorf, Germany

    • T Schroeder
    •  & G Kobbe
  9. Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    • N Kroeger

Authors

  1. Search for M Heuser in:

  2. Search for M Meggendorfer in:

  3. Search for M M A Cruz in:

  4. Search for J Fabisch in:

  5. Search for S Klesse in:

  6. Search for L Köhler in:

  7. Search for G Göhring in:

  8. Search for C Ganster in:

  9. Search for K Shirneshan in:

  10. Search for A Gutermuth in:

  11. Search for S Cerny-Reiterer in:

  12. Search for J Krönke in:

  13. Search for V Panagiota in:

  14. Search for C Haferlach in:

  15. Search for C Koenecke in:

  16. Search for U Platzbecker in:

  17. Search for C Thiede in:

  18. Search for T Schroeder in:

  19. Search for G Kobbe in:

  20. Search for S Ehrlich in:

  21. Search for K Stamer in:

  22. Search for K Döhner in:

  23. Search for P Valent in:

  24. Search for B Schlegelberger in:

  25. Search for N Kroeger in:

  26. Search for A Ganser in:

  27. Search for D Haase in:

  28. Search for T Haferlach in:

  29. Search for F Thol in:

Competing interests

The authors declare no conflict of interest.

Corresponding author

Correspondence to M Heuser.

Supplementary information

About this article

Publication history

Published

DOI

https://doi.org/10.1038/leu.2015.49

Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)

Further reading